Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product... ( NEWPORT Ky. Oct. 29 /- Xanodyne Pharm...)

Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio

Date:10/29/2009

NEWPORT, Ky., Oct. 29 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today the completion of $50 million in equity financing. The round was led by Longitude Capital with participation from new investors Skandia and Silver Point Capital. Other current investors that participated in the financing include MPM Capital, LLC, AIG Investments' sponsored funds, Perseus-Soros Biopharmaceutical Fund, Blue Chip Venture Company, HealthCare Ventures, LLC, and Union Springs, LLC. Aquilo Partners, L.P., a life science investment bank, acted as the exclusive placement agent for the financing.

Michael J. Valentino, President and CEO commented, "I am extremely pleased to have secured additional financial resources which will be used to support our ongoing development and commercialization strategy for our emerging product portfolio."

In June 2009, Xanodyne received Food and Drug Administration (FDA) approval for Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules, a new treatment option for relief of mild to moderate acute pain in adults (18 years of age or older). Zipsor was launched nationally to physicians and patients in September.

In addition, the company expects FDA action soon on Lysteda(TM) (formerly XP12B), an oral tranexamic acid product under priority review. If approved, Lysteda would be the first and only oral therapeutic agent indicated specifically for the treatment of women suffering from cyclic heavy menstrual bleeding.

Valentino added, "The continued commitment from our investor groups allows us to remain focused on aggressively executing our product commercialization plans and optimizing the other assets in our portfolio."

About Xanodyne

Xanodyne Pharmaceuticals, Inc., which commenced operations in 2001, is an integra
'/>"/>

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Globus Medical Raises $110 Million in Series E Financing Round
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Light Sciences Oncology Raises $40.1 Million in Series C Financing
6. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
7. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
8. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
9. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
10. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
11. SynergEyes, Inc. Raises $13.3 Million in Series C Financing

Post Your Comments:

(Date:11/23/2009)...RK,Nov.23/PRNewswire/--Reportlinker.comannouncesth...e. ,, IndiaDentalDevicesInvestmentOpportunitie...eportlinker.com/p0164620/India-Dental-Devices-Inve...5.html#utm_source=prnewswire&utm_medium=pr&..., IndiaDentalDevicesInvestmentOpportunities,Ana...

(Date:11/23/2009)...RK,Nov.23/PRNewswire/--Reportlinker.comannouncesth...e. ,, HolterMonitoringSystems-AGlobalMarketRev...Holter-Monitoring-Systems---A-Global-Market-Review...utm_campaign=prnewswire ,, Cardiovascularmo...gh-riskpatientsneedtobecontinuouslymonitoredduring...

(Date:11/23/2009)...VUE,Wash.,Nov.23/PRNewswire/--LightSciencesOncolog...,ChairmanoftheBoard,Elekta,toanewlycreatedseatonit...gnumerousmedical-productcompanies,includingElekta,...ddighbringsadditionalstrengthinbusinessdevelopment...."Mr.Seddighisaworldleaderincancer-therapybusiness...

[0] Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 [0] Reportlinker Adds Holter Monitoring Systems - A Global Market Review [0] Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors

...Highlighted at ATS 2009 , , SUNNYVALE, Calif., Ma...2 (AIR2) Trial of the Alair(R) Bronchial Thermopla...unced today at ATS 2009, the International Confere..., Calif . The AIR2 results demonstrated statistic...easurements, reductions in asthma attacks (severe ...

... Interventional(TM)/Possis(R) today announced that...cocath(R) Technology closer to market as an option...ates and Europe who suffer from Peripheral Arteria...ction of physician investigators for U.S. clinical...rt manufacturing facility. , , (Logo: http://w...

Other Medicine Technology:Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 2 Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 3 Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 4 Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 2 Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 3 Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 4 Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 5

Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data

(Date:11/24/2009)... Along with his state-of-the-art websit...al media to interact with patients and share infor...practice and the procedures that he offers. , ...r 24, 2009 -- North Carolina plastic surgeon Dr....tworking site Facebook to expand his reach and kee...

(Date:11/24/2009)... The GeoPense World Volunteer Computing...t applies the Quantum Monte Carlo method to proble...e molecules important in life science research. Th...ulation), Einstein@home (gravity wave detection), ... underway. , (PRWEB) Nove...

(Date:11/24/2009)... Developed by Opticom Data Research, Fl...-examination of the eye. , ... FloatScope is a new hand-held device for self-exa...arious ocular health conditions such as floaters a... the functioning of the iris., , , FloatScope use...

(Date:11/23/2009)...obolomics study by researchers from Virginia Commo...d that impaired peroxisomal oxidation of polyunsat...rogression of nonalcoholic fatty liver (NAFL) to n...so found significantly higher plasma monounsaturat...and NASH. Full findings appear in the December is...

(Date:11/23/2009)... Same Day STD Testing now provides supe...ypes of STD,s, including Chlamydia, Herpes, HIV, G... anonymously. , (PRWEB) N...the web at: http://www.samedaystdtesting.com is ...testing, which is now available to accurately and ...

Breaking Medicine News(10 mins):Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 2 Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 3 Health News:GeoPense Announces it has Joined QMC@home Project 2 Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2 Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2 Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2

[0] North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community [0] GeoPense Announces it has Joined QMC@home Project [0] FloatScope - A New Device for Self-Viewing Eye Floaters [0] Metobolomics uncovers key indicators of nonalcoholic fatty liver disease [0] 100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing

...h Annual IMPACT Awards) , , PHILADELPHIA, Jan. 19...arch-based pharmaceutical and healthcare companies...ine 12th Annual IMPACT Awards for providing access...axoSmithKline in Philadelphia where grants will go...

...FDA advises consumers not to eat anything but jars... , , MONDAY, Jan. 19 (HealthDay News) -- ...s continued without letup Monday, as more companie...nsumers should avoid peanut butter products contai...

...re at Risk for ,Pregorexia, , , PHOENIX, Jan. 19 ...sorders ( www.remudaranch.com ), the nation,s lead...e,s a new pressure to look perfect while pregnant....enda Woods, MD, director of medical services at Re...

...lden Globe Awards was broadcast with hundreds of "...s year thanks to the Kari Feinstein,s 2009 Style L...uests of the style lounge included Paris Hilton, J... Now organization. , , To view the Multimedia New...

...pics at this week,s American Academy of Facial Pla...nter Symposium at The Peaks Resort was minimally i...ume -- a new technique which helps to achieve a mo....C.S. During his speech, entitled "Using Orbital ...

...ovation Discusses the Impact of the Economic Crisi...H, Va., Jan. 19 A new report released today f...ding non-profit advisory firm to health providers,...s a result of the economic crisis. Conducted in la...

Other Medicine News:Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 2 Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 3 Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 4 Health News:Peanut Butter Product Recalls Mount 2 Health News:Peanut Butter Product Recalls Mount 3 Health News:Remuda Ranch Reports More Women Seek to Be Thin During Pregnancy 2 Health News:Photos: Opalescence Treswhite Supreme Adds Glimmer to 'Twilight' Film Actor's Smile 2 Health News:Latest Facelifting Techniques Include Fat Repositioning to Deliver More Youthful, Natural Results 2 Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 2 Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 3 Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 4

GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding Peanut Butter Product Recalls Mount Remuda Ranch Reports More Women Seek to Be Thin During Pregnancy Photos: Opalescence Treswhite Supreme Adds Glimmer to 'Twilight' Film Actor's Smile Latest Facelifting Techniques Include Fat Repositioning to Deliver More Youthful, Natural Results Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009

...PowerPath is IMPACs comprehensive information syst...ogy laboratories to integrate and streamline their...h a single, intuitive software solution. Thousands...stitutions have proven PowerPaths unique "case-cen...

...nse to the needs of its users for onboard data man...nched the latest development in its haematology an...se unique new features, the PENTRA XL 80 incorpora...g fully automated throughput of 80 samples per hou...

SG-2002 Stand-Alone Ganzfeld

...10 is the ultimate in clinical color vision tests....red/green or blue/yellow color vision losses that ... from Plaquenil, for example), early optic neuriti...eneration. Additionally it is fast and accurate in...

Medicine Products:

Tamtron PowerPath Anatomic Pathology System™ABX Pentra XL 80 SG-2002 Stand-Alone Ganzfeld AQT-10

Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product...( NEWPORT Ky. Oct. 29 /- Xanodyne Pharm...),Health